Influence of
GAS5
P2Y12
clopidogrel
coronary artery disease
miR‐223‐3p
rs55829688
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
02 11 2021
02 11 2021
Historique:
pubmed:
30
10
2021
medline:
1
3
2022
entrez:
29
10
2021
Statut:
ppublish
Résumé
Background Dual antiplatelet therapy based on aspirin and P2Y12 receptor antagonists such as clopidogrel is currently the primary treatment for coronary artery disease (CAD). However, a percentage of patients exhibit clopidogrel resistance, in which genetic factors play vital roles. This study aimed to investigate the roles of GAS5 (growth arrest-specific 5) and its rs55829688 polymorphism in clopidogrel response in patients with CAD. Methods and Results A total of 444 patients with CAD receiving dual antiplatelet therapy from 2017 to 2018 were enrolled to evaluate the effect of
Identifiants
pubmed: 34713722
doi: 10.1161/JAHA.121.021129
pmc: PMC8751826
doi:
Substances chimiques
MIRN223 microRNA, human
0
MicroRNAs
0
Platelet Aggregation Inhibitors
0
Clopidogrel
A74586SNO7
Cytochrome P-450 CYP2C19
EC 1.14.14.1
Ticlopidine
OM90ZUW7M1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e021129Références
Circulation. 2016 Sep 6;134(10):e123-55
pubmed: 27026020
Biomed Res Int. 2015;2015:981841
pubmed: 26221610
Cell. 2018 Jul 26;174(3):564-575.e18
pubmed: 30033362
Mol Cancer. 2019 Nov 29;18(1):171
pubmed: 31779616
Nat Commun. 2016 Nov 04;7:13287
pubmed: 27811843
Exp Cell Res. 2018 Aug 15;369(2):348-355
pubmed: 29859752
Lancet. 2015 Jan 10;385(9963):117-71
pubmed: 25530442
J Thromb Thrombolysis. 2014 Jul;38(1):65-72
pubmed: 24202700
Mol Cancer. 2019 Mar 2;18(1):33
pubmed: 30825877
J Cell Physiol. 2019 Jul;234(7):11348-11359
pubmed: 30511472
J Am Coll Cardiol. 2007 Apr 10;49(14):1505-16
pubmed: 17418288
J Cell Biochem. 2019 Nov;120(11):18678-18688
pubmed: 31429119
Circ Res. 2013 Feb 15;112(4):595-600
pubmed: 23283721
Thromb Haemost. 2014 May 5;111(5):943-50
pubmed: 24402637
Front Pharmacol. 2016 Nov 24;7:453
pubmed: 27932982
Thromb Res. 2013 Jun;131(6):508-13
pubmed: 23498169
Mol Cancer. 2020 May 30;19(1):98
pubmed: 32473645
Clin Pharmacol Ther. 2013 Sep;94(3):317-23
pubmed: 23698643
Blood. 2006 Oct 1;108(7):2244-7
pubmed: 16772608
Lancet. 2010 Oct 16;376(9749):1312-9
pubmed: 20801494
Nat Rev Genet. 2017 Jun;18(6):331-344
pubmed: 28286336
Am Heart J. 2019 Sep;215:1-11
pubmed: 31255895
Clin Pharmacol Ther. 2020 Nov;108(5):1067-1077
pubmed: 32472697
J Am Coll Cardiol. 2010 Sep 14;56(12):919-33
pubmed: 20828644
Clin Pharmacol Ther. 2017 Jun;101(6):791-802
pubmed: 27981573
Cell. 2018 Jul 26;174(3):576-589.e18
pubmed: 30033361
N Engl J Med. 2009 Jan 22;360(4):354-62
pubmed: 19106084
Circ Cardiovasc Interv. 2017 Jun;10(6):
pubmed: 28606999
Circulation. 2018 May 22;137(21):2231-2245
pubmed: 29420189
Arterioscler Thromb Vasc Biol. 2020 Jun;40(6):1432-1440
pubmed: 32295424
Br J Pharmacol. 2004 Aug;142(8):1325-31
pubmed: 15265806
Cancer Manag Res. 2020 Nov 27;12:12259-12267
pubmed: 33273862
Med Sci Monit. 2017 Dec 21;23:6042-6048
pubmed: 29267258
Circulation. 2014 Nov 4;130(19):1749-67
pubmed: 25070666
Nucleic Acids Res. 2014 Jan;42(Database issue):D92-7
pubmed: 24297251
Mol Cell Biochem. 2021 Feb;476(2):949-957
pubmed: 33128668
Clin Pharmacol Ther. 2015 Jun;97(6):650-8
pubmed: 25704243
Int J Biol Macromol. 2018 Dec;120(Pt A):371-377
pubmed: 30099044
Mol Ther Nucleic Acids. 2019 Sep 6;17:644-656
pubmed: 31400607
J Am Coll Cardiol. 2013 Feb 26;61(8):872-9
pubmed: 23333143
Nat Struct Mol Biol. 2009 Sep;16(9):961-6
pubmed: 19668211
Blood. 2014 Jul 24;124(4):493-502
pubmed: 24904119
Eur J Clin Pharmacol. 2021 Mar;77(3):359-368
pubmed: 33089397
Chin Med J (Engl). 2014;127(14):2571-7
pubmed: 25043069
Eur J Pharmacol. 2019 Jan 15;843:154-161
pubmed: 30468731
JAMA Cardiol. 2019 Apr 1;4(4):342-352
pubmed: 30865215
N Engl J Med. 2010 Oct 28;363(18):1704-14
pubmed: 20979470
Platelets. 2018 Jul;29(5):446-454
pubmed: 28727490
Thromb Res. 2017 Sep;157:97-102
pubmed: 28734158
J Atheroscler Thromb. 2014;21(1):64-76
pubmed: 24088578
Curr Vasc Pharmacol. 2015;13(5):566-77
pubmed: 25440595
Life Sci. 2020 Nov 1;260:118388
pubmed: 32890602
Exp Mol Pathol. 2020 Dec;117:104529
pubmed: 32926880
Leuk Lymphoma. 2017 Aug;58(8):1948-1957
pubmed: 27951730
Circulation. 2015 Jul 7;132(1):47-58
pubmed: 25934838
Gene. 2018 Dec 15;678:226-232
pubmed: 30096456
Mol Neurobiol. 2021 Jul;58(7):3198-3207
pubmed: 33638792
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):203-210
pubmed: 31504375
Eur J Clin Pharmacol. 2010 Nov;66(11):1131-6
pubmed: 20669013
Carcinogenesis. 2015 Oct;36(10):1136-43
pubmed: 26163879
Circulation. 2012 Dec 18;126(25):e354-471
pubmed: 23166211
Nat Rev Mol Cell Biol. 2021 Feb;22(2):96-118
pubmed: 33353982
Mol Cancer. 2020 Jan 29;19(1):18
pubmed: 31996265
Mol Ther Nucleic Acids. 2020 Mar 6;19:84-96
pubmed: 31830648
Front Pharmacol. 2018 Sep 19;9:1039
pubmed: 30283338
J Cell Biochem. 2019 Sep;120(9):14518-14530
pubmed: 31026096
Int Immunopharmacol. 2020 Aug;85:106614
pubmed: 32470877
Cardiovasc Drugs Ther. 2019 Apr;33(2):129-137
pubmed: 30783954
Elife. 2015 Aug 12;4:
pubmed: 26267216
Nature. 2001 Jan 11;409(6817):202-7
pubmed: 11196645